Prof Mark Cooper (Monash University, Melbourne, AU) discusses CARMELINA - Cardiovascular and renal microvascular outcome study linagliptin in patients with type 2 diabetes mellitus.

Filmed by Radcliffe Cardiology on site at EASD 2018.

Interviewer: Rob Barclay

Videographer: Mike Knight